CRP and chronic kidney disease: Given the beneficial effects of omega-3 polyunsaturated fatty acids (PUFAs), such as anti-inflammatory, antiplatelet, and its alleviating effect on aspirin responsiveness in drug-resistant patients,7 this study aimed to evaluate the effect of pre-treatment with a single dose of omega-3 on post-PCI hs-CRP level and 30-day MACE in CKD patients.